Patient Guide: Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 7 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05998642
Status: 🟢 Enrolling Now
Condition: Non-hodgkin Lymphoma
Phase: PHASE2

Where You Can Participate

This study is available at 7 locations across the country.

Top locations include:
  • • Calgary, Alberta
  • • Vancouver, British Columbia
  • • Hamilton, Ontario
  • • And 4 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma - Join Clinical Trial NCTNCT05998642

How to Join This Clinical Trial - NCTNCT05998642

Learn how to participate in this PHASE2 trial studying an investigational therapy for Non-hodgkin Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-hodgkin Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-hodgkin Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05998642 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 7 locations. Find a study site near you:

Clinical Research Site

Calgary, Alberta T2N 5G2 - Canada

Status: RECRUITING

Clinical Research Site

Vancouver, British Columbia V5Z 4E6 - Canada

Status: RECRUITING

Clinical Research Site

Hamilton, Ontario L8V 5C2 - Canada

Status: RECRUITING

Clinical Research Site

Ottawa, Ontario K1H 8L6 - Canada

Status: RECRUITING

Clinical Research Site

Toronto, Ontario M5G 2M9 - Canada

Status: RECRUITING

Clinical Research Site

Montreal, Quebec H4A 3J1 - Canada

Status: RECRUITING

Clinical Research Site

Quebec City, Quebec G1J 1Z4 - Canada

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Non-hodgkin Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships